The Death of Yoo Ji-won and the Medical Gap in Korea's Mass Running Races

At 08:49 on October 11, on a central Seoul course, a runner entered the 21st kilometre of the half marathon. She was about 500 metres from the finish line. That is the stretch where heart rate, core temperature, and nervous-system arousal peak for almost every endurance athlete in a race. Yoo Ji-won, 25, collapsed on that very stretch. She received CPR on site, was taken by ambulance, and did not survive.

She was not a professional track star. She was a graduate researcher in AI and semiconductors at KAIST. But in Korea's amateur running scene, Yoo Ji-won was one of the strongest female figures: a 2:56:32 marathon, a 1:22:01 half marathon, a 10 km of about 36 minutes. That set of marks places her in the strong amateur tier — above most recreational runners, below the professional threshold.

Seoul Race 2026 is a large mass-participation event with roughly 12,000 athletes across two distances, the half marathon and 11 km, running through the central axes of Seoul Plaza, Gwanghwamun, and Dongdaemun. It does not belong to the World Athletics label system. It is an event where runners of every level start together.

Yoo Ji-won began running in 2026, but only focused on performance from the summer of 2026. Within roughly 8 to 12 months, she reached a sub-three-hour marathon. In amateur running, “sub3” is a line of honour — a milestone most runners need years to touch. She touched it in a compressed span.

Alongside that was a demanding career: full-time research at KAIST. According to the facts that remain, she entered the lab from 9 a.m., ran for about two hours at 8 p.m., and on some days returned to the lab after training. No coach is mentioned. No training group. Alone, inside a dense academic schedule.

Years ago, I sat in the third row of a women's final and counted the spectators myself: 127 people, not a single reporter. That night I understood that silence is not an accidental omission but an implicit statement about value. The silence around the medical infrastructure of mass running races is the same. It is not that there is nothing to say. It is that no one was assigned to count.

That final was not written by anyone, so I wrote it.

Start with the most honest figure: the 21.0975 km half marathon in 1:22:01, a pace of 3 minutes 53 seconds per kilometre. That is the speed of a strong amateur, far ahead of the crowd. But set against the 2:56:32 marathon — a pace of 4 minutes 11 seconds per kilometre — a gap appears. Her half-marathon speed was markedly faster than her own marathon endurance. This is the familiar profile of the amateur runner: quick over short distances, fading over long ones. And it is precisely this profile that tends to push people to raise marathon volume aggressively to close the gap.

The second point is the speed of progression. From 2026 to the summer of 2026, she ran like someone who loved movement. From the summer of 2026 to March 2026, she ran like someone racing for marks. That curve is far steeper than the typical development path of an amateur runner. I do not read it as an accusation. I read it as a signal about training load.

The third point is race density. Within the same March window, she completed a marathon and a half marathon. In April, she won a 10 km. In October, she stood at the start of another half marathon. Four races in a year, with two long endurance efforts only weeks apart. For an amateur, that is a moderate-to-high density, and every race is a withdrawal from the recovery account.

The fourth point is the weather. A Seoul October morning, around 8:49, is favourable for endurance running: cool, low humidity. Favourable conditions reduce heat risk but do not remove it. And they say nothing about the risks inside a runner's body.

In an 18 m² room, I watched 52 matches and a revolution. That habit taught me that data only means something when tied to a person. For a 25-year-old, congenital or structural cardiac causes — hypertrophic cardiomyopathy, coronary anomalies, arrhythmogenic cardiomyopathy, channelopathies — usually dominate statistically compared with older cohorts. That is a population pattern, not an inference about this specific case. With no pre-participation cardiovascular screening data, no one has the right to conclude a cause for an individual. I keep that silence, because it is the only honest thing.

Another risk rarely mentioned is exercise-associated hyponatremia (EAH). Cool weather makes runners drink more while sweating less, and that electrolyte imbalance can itself be dangerous. This is a low-to-medium risk, but it belongs to the environmental causes that any review must rule out.

Most reports on Yoo Ji-won's death stop at two words: “cardiac arrest.” Some outlets called her a “hot girl runner.” Both framings miss what matters.

Labelling an amateur female athlete by her appearance is an editorial choice, not a fact. It reduces a person with a 2:56:32 mark to an image. She did not need a status. She needed a seat that gets written about. And that seat, in women's sport, is usually written with data, not with looks.

“Cardiac arrest” in many reports describes the mechanism of collapse on site, not a diagnosed cause. When media assign a medical cause before an official conclusion, they create a harmful kind of informational noise: it makes the public believe the answer exists, while the investigation may still be open.

The biggest blind spot is not naming. It is the race's medical infrastructure. For a 12,000-person event, the decisive structural variables are AED density, medical-station density, the number of on-course responders, and evacuation routes. None of those facts is disclosed. Time from collapse to defibrillation is the decisive variable in a survivable cardiac arrest. And that is exactly what we do not know.

This event sits inside a rapidly expanding ecosystem: large city races, a layer of “running influencers” sharing their training journeys on social media, and a culture of chasing benchmarks — a sub3 marathon, a sub1:30 half. Yoo Ji-won was a prominent figure in that layer, which explains the depth of public mourning. But that very pace of expansion is what makes the question of health screening more urgent.

Korea's amateur running boom is growing faster than the health-screening infrastructure that comes with it. That does not make running dangerous. It only means the scale has outgrown what a registration bib can carry on behalf of a medical system.

Yoo Ji-won does not need to be remembered as a tragedy. She needs to be remembered as a marker: the runner who went sub3 in a year, who entered the lab at 9 and ran at 8. If her death forces major races to disclose their AED density and response times, that is the only thing that can keep the final 500 metres from becoming meaningless.

Tactics do not need an audience. They need eyes that truly know how to look. And this time, those eyes must look at a detail that is not on the course: at the information void the race left behind after the finish line.